University Hospitals Birmingham NHS Foundation Trust

Medicines A–Z

L

Status Drug name NICE TAs Comments
Status: Red Liraglutide (Saxenda®) (GLP1s should all be prescribed by brand name)

The use of Liraglutide for this indication is restricted to prescribing in secondary care by a specialist multidisciplinary Tier 3 weight management service with a commercial agreement in place.

Prescribe by brand (Saxenda®) to avoid patients inadvertently receiving a different product licensed for type 2 diabetes.

Status: Green Liraglutide (Victoza®) injection (GLP1s should all be prescribed by brand name)

THIS IS FOR DIABETES ONLY. Prescribe by brand (Victoza®) to avoid patients inadvertently receiving a different product licensed for obesity.

1.8 mg is non-formulary.

Status: Amber Lisdexamfetamine

ESCAs and additional advice in relation to age of patient and CCG

Status: Red Lisdexamfetamine

ESCAs and additional advice in relation to age of patient and CCG

Status: Green Lisinopril tablets
Status: Amber Lithium carbonate M/R tablet (Priadel)

Specialist initation only, ESCA

Status: Amber Lithium citrate liquid priadel

Specialist initiation only, ESCA

Status: Green Lixisenatide (Lyxumia®)

1st line choice GLP1 for co-prescribing with insulin. RICaD.

Status: Green Lizinna

Umbrella service only

Status: Amber Loestrin 20

Umbrella servide only - puberty induction

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top